# Helicore Bioventures I, Inc. — Form D

Helicore Bioventures I, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2024-01-19. The offering totals $65.0M, of which $15.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2024-01-19
- Form: D
- Accession: 0002008794-24-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $65.0M
- Amount sold: $15.0M
- Remaining: $50.0M
- Investors: 8
- Date of first sale: 2024-01-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-502956

## Issuer

- Name: Helicore Bioventures I, Inc.
- CIK: 0002008794
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 619 W 54TH STREET, SUITE 702, NEW YORK, NY, 10019
- Phone: 212-203-4217

## Officers, directors & promoters (10)

| Name | Role | Location |
| --- | --- | --- |
| Rishi Young Gupta | Director | New York, NY |
| Jing Liang | Director | New York, NY |
| Brian Young Liu | Director | New York, NY |
| Hugh Young Rienhoff, Jr. | Director | New York, NY |
| Carl Young Rizzuto | Director | New York, NY |
| Patrick R Crutcher | Executive Officer | New York, NY |
| Jing Liang | Executive Officer | New York, NY |
| Patrick R Crutcher | Promoter | New York, NY |
| Jing Liang | Promoter | New York, NY |
| Hugh Young Rienhoff, Jr. | Promoter | New York, NY |

## More

- [CIK 2008794 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2008794&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002008794-24-000003.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.